More on BMY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+1.2% Growth)
- Ratings (5.2 Score)
- Holders
- Dividends (3% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/6/21 *Est.)
- M&A (9/30/19 *Est)
- M&A (12/31/20 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Bristol-Myers Squibb (NY:BMY)
Delayed: 65.60 +0.14 (0.21%)
Prev. Close $65.46  
Open$65.42 
52 Wk High$77.12 
52 Wk Low$49.03 
Day High$65.80 
Day Low$65.13 
P/E 42.60  
EPS$1.54 
Volume6,668,359 

Friends, Peers and Foes (?): BLUE, MYOK, PFE, CELG, EXEL (more...)

May 18, 2021 09:37 AM Warren Buffett's Berkshire Hathaway (BRK-A) Now Almost Out of Wells Fargo (WFC), Invests Further into Verizon (VZ) and Kroger (KR), More Selling than Buying Says Analyst
May 18, 2021 09:31 AM Pre-Open Stock Movers 05/18: (AGEN) (ULBI) (AGTI) Higher; (EVFM) (DM) (XONE) Lower (more...)
May 18, 2021 07:31 AM Agenus (AGEN) and Bristol Myers Squibb (BMY) Announce Exclusive Global License for Agenus' Anti-TIGIT Bispecific Antibody Program
May 18, 2021 07:30 AM Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program
May 18, 2021 07:30 AM Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program
May 18, 2021 07:30 AM Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program
May 18, 2021 06:59 AM Bristol Myers Squibb to Take Part in UBS Global Healthcare Virtual Conference
May 17, 2021 11:22 PM Buffett's Berkshire Hathaway Enters Aon plc (AON), Sells Most of Wells Fargo (WFC) Stake
May 15, 2021 12:15 PM Bristol Myers Squibb Presents Late-Breaking Phase 3 Data Demonstrating Health Status Benefits of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy at American College of Cardiology
May 12, 2021 11:44 AM Bristol Myers Squibb (BMY) Presents New Research at ASCO and EHA 2021 Featuring Novel Approaches and Demonstrating Significant Progress to Improve Survival in Cancer and Blood Disorders
View All Articles